Myocardial ischaemia in patients with primary APS:: a 13N-ammonia PET assessment

被引:5
作者
Alexanderson, E. [1 ,2 ]
Gomez-Leon, A. [1 ]
Vargas, A. [1 ]
Romero, J. L. [2 ]
Fernandez, C. Sierra [2 ]
Valero, M. Rodriguez [2 ]
Garcia-Rojas, L. [2 ]
Meave, A. [1 ]
Amigo, M. -C. [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Nacl cardiol Ignacio Cahvez, PET, Mexico City, DF, Mexico
[2] Univ Nacl Autonoma Mexico, PET Ciclotron Unit, Mexico City, DF, Mexico
关键词
primary anti-phospholipid syndrome; ischaemia; positron emission tomography; N-13-ammonia; thrombosis; coronary disease; ischaemic heart disease; autoimmune diseases; heart; cardiovascular imaging;
D O I
10.1093/rheumatology/ken084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Evaluate the presence and severity of myocardial ischaemia in a population of asymptomatic patients with primary APS (PAPS) using N-13-ammonia PET. Methods. We studied 36 patients, 18 with a diagnosis of PAPS and 18 healthy volunteers. All patients underwent a two-phase (reststress) N-13-ammonia PET. Myocardial perfusion images were acquired and then analysed by two experts in the field. Results. We found ischaemia in 7/18 asymptomatic PAPS patients (38.8). The anterolateral wall was the most commonly affected cardiac territory [5/7 PAPS patients (71.4)]. In a severity analysis, we found that five patients (71.4) had mild ischaemia, one patient (14.2) had moderate ischaemia and another one (14.2) had severe defects. All the healthy volunteers studied showed normal myocardial perfusion images. Conclusion. An important proportion of PAPS patients, even when asymptomatic, showed myocardial perfusion defects assessed with PET. Most of the ischaemic patients had mild defects and the anterolateral wall was the territory mainly affected.
引用
收藏
页码:894 / 896
页数:3
相关论文
共 31 条
[1]  
Alexánderson Erick, 2006, Arch. Cardiol. Méx., V76, P111
[2]   ANTIPHOSPHOLIPID ANTIBODIES, THROMBOSIS AND ATHEROSCLEROSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A UNIFYING MEMBRANE STRESS SYNDROME HYPOTHESIS [J].
AMES, PRJ .
LUPUS, 1994, 3 (05) :371-377
[3]   THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
ORDIROS, J ;
DERKSEN, RHWM ;
MACHIN, SJ ;
BARQUINERO, J ;
OUTT, HH ;
HARRIS, EN ;
VILARDELLTORRES, M ;
HUGHES, GRV .
MEDICINE, 1989, 68 (06) :366-374
[4]  
ASHERSON RA, 1992, J RHEUMATOL, V19, P508
[5]   IMMUNOPATHOLOGY OF CARDIAC LESIONS IN FATAL SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BIDANI, AK ;
ROBERTS, JL ;
SCHWARTZ, MM ;
LEWIS, EJ .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (06) :849-858
[6]   Innate and acquired immunity in atherogenesis [J].
Binder, CJ ;
Chang, MK ;
Shaw, PX ;
Miller, YI ;
Hartvigsen, K ;
Dewan, A ;
Witztum, JL .
NATURE MEDICINE, 2002, 8 (11) :1218-1226
[7]  
CARIOU R, 1988, THROMB HAEMOSTASIS, V60, P54
[8]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027
[9]   ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH UNSTABLE ANGINA [J].
DIAZ, MN ;
BECKER, RC .
CARDIOLOGY, 1994, 84 (06) :380-384
[10]   Myocardial perfusion defects in patients with autoimmune diseases: a prospective study. Analysis of two diagnostic tests [J].
Espinola-Zavaleta, N ;
Alexanderson-Rosas, E ;
Granados, N ;
Soto, ME ;
Amigo, MC .
LUPUS, 2006, 15 (01) :38-43